GCP
YARW

GSA Capital Partners’s Yarrow Bioscience YARW Stock Holding History

GSA Capital Partners’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47K Buy
+1,431
New +$46.4K ﹤0.01% 1662
2026
Q1 		– Sell
-1,079
Closed -$31K – 2203
2025
Q4 		$31K Buy
1,079
+361
+50% +$7.25K ﹤0.01% 1592
2025
Q3 		$12K Buy
718
+449
+167% +$14.7K ﹤0.01% 1594
2025
Q2 		$22K Buy
+269
New +$17.5K ﹤0.01% 1689
2022
Q2 		– Sell
-263
Closed -$154K – 1835
2022
Q1 		$154K Buy
263
+21
+9% +$12.5K 0.02% 1227
2021
Q4 		$222K Buy
242
+139
+135% +$149K 0.03% 1144
2021
Q3 		$128K Buy
+103
New +$200K 0.01% 1302

Other funds holding YARW

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

GSA Capital Partners's YARW Position: Q2 2026 in Review

GSA Capital Partners opened a new position in Yarrow Bioscience (YARW) in Q2 2026: 1,431 shares worth $47K. The stake represents ﹤0.01% of the portfolio and ranks #1662 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in YARW as recently as Q4 2025.

GSA Capital Partners first reported a position in YARW in Q3 2021 and has held it in 7 quarters since. The position peaked at $222K in Q4 2021. 40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

  • GSA Capital Partners held 1,431 shares of Yarrow Bioscience worth $47K as of Q2 2026.
  • Yarrow Bioscience was a new GSA Capital Partners position in Q2 2026.
  • Yarrow Bioscience made up ﹤0.01% of GSA Capital Partners's portfolio in Q2 2026, its #1662 holding.
  • GSA Capital Partners first reported a position in Yarrow Bioscience in Q3 2021 and has held it in 7 quarters since.
  • GSA Capital Partners's Yarrow Bioscience position peaked at $222K in Q4 2021.
  • 40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.